13F

Stock

MAIA Biotechnology, Inc.

MAIA · held by 26 managers

Reported value

$4.07M

Holders

26

+1 new · −0 exited

Holders’ est. mark

−$9

Price effect on 2 books still in the name

Largest holder

$1.77M

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard1.15M$1.77MHeld
Centric Wealth Management586.4K$1.14MHeld
GEODE CAPITAL MANAGEMENT, LLC296.7K$454.1KHeld
BlackRock, Inc.107.2K$164.1KHeld
JANE STREET GROUP, LLC78.8K$120.5KHeld
State Street75.5K$115.6KHeld
NORTHERN TRUST CORP39K$59.7KHeld
BRIDGEWAY CAPITAL MANAGEMENT, LLC36K$55.1KHeld
Creative Planning28.8K$44.1KHeld
RITHOLTZ WEALTH MANAGEMENT23.1K$35.3KHeld
Centerpoint Advisory Group15.7K$24.1KHeld
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC14.8K$22.6KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP14.3K$21.9KHeld
StoneX Group Inc.10.2K$15.7KHeld
OSAIC HOLDINGS, INC.8.33K$12.8KHeld
Daytona Street Capital LLC7.5K$11.5KHeld
UBS Group AG2.17K$3.32KHeld
CURIO WEALTH, LLC2K$2.96KHeld
CITIGROUP INC1.74K$2.66KHeld
MORGAN STANLEY1K$1.53K−$8Added$249
MAI Capital Management675$1.03KHeld
SRH ADVISORS, LLC653$999Held
TUCKER ASSET MANAGEMENT LLC341$522New
JONES FINANCIAL COMPANIES LLLP228$349Held
BANK OF AMERICA CORP /DE/30$46−$1Added$1
Cambridge Investment Research Advisors, Inc.10.6K$16Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.